Black Diamond Therapeutics Presents Actual-World Therapy Practices and Affected person Outcomes in Newly Recognized NSCLC Sufferers with Non-Classical Mutations on the European Society for Medical Oncology (ESM By Investing.com
Therapy information had been analyzed from 3,276 circumstances of sufferers with newly…
Affinia Therapeutics Publicizes the Appointment of Rami Daoud as Chief Business and Monetary Officer By Investing.com
Trade veteran Daoud brings greater than 25 years' expertise in enterprise improvement…
Acquire Therapeutics Initiates $50 million fairness distribution By Investing.com
Acquire Therapeutics, Inc. (NASDAQ:GANX), a pharmaceutical firm, introduced on Thursday the institution…
Plus Therapeutics inventory sees decreased goal after softer-than-expected Q2 outcomes By Investing.com
On Tuesday, Ascendiant Capital revised its value goal for NASDAQ:PSTV, Plus Therapeutics…
Destiny Therapeutics shares maintain regular on up to date analyst ranking By Investing.com
On Wednesday, TD Cowen maintained a Maintain ranking on shares of Destiny…
Nykode Therapeutics Broadcasts Issuance of Key Patent Overlaying Individualized Neoantigen Based mostly Vaccines By Investing.com
OSLO, Norway, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE:…
Ra capital administration sells $3.8 million in AN2 therapeutics inventory By Investing.com
Traders following the actions of RA Capital Administration, L.P. may be aware…
Akero Therapeutics COO sells shares value over $130k By Investing.com
Jonathan Younger, the Chief Working Officer of Akero Therapeutics, Inc. (NASDAQ:), has…
Halozyme Therapeutics hits 52-week excessive, reaching $56.66 By Investing.com
Halozyme (NASDAQ:) Therapeutics, Inc. (HALO) has reached a brand new 52-week excessive,…
Scotiabank sees ‘deep worth’ in Sage Therapeutics inventory regardless of research setback By Investing.com
On Wednesday, Scotiabank adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE), decreasing the…
